Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 10:25 am Sale | 13G | Baudax Bio Inc. BXRX | BLACK HORSE CAPITAL LP | 0 0% | -500,000 (Position Closed) | View |
| 2024-02-06 11:12 am Purchase | 13G | Baudax Bio Inc. BXRX | INTRACOASTAL CAPITAL LLC | 814,383 1.8% | 787,291 (+2905.99%) | View |
| 2023-07-10 5:12 pm Purchase | 13G | Baudax Bio Inc. BXRX | BLACK HORSE CAPITAL LP | 500,000 6.9% | 500,000 (New Position) | View |
| 2023-02-14 12:18 pm Purchase | 13G | Baudax Bio Inc. BXRX | ARMISTICE CAPITAL LLC | 1,165,709 4.99% | 1,165,709 (New Position) | View |
| 2023-02-08 06:06 am Purchase | 13G | Baudax Bio Inc. BXRX | INTRACOASTAL CAPITAL LLC | 27,092 5.1% | 27,092 (New Position) | View |
| 2022-09-06 06:13 am Purchase | 13G | Baudax Bio Inc. BXRX | INTRACOASTAL CAPITAL LLC | 1,091,652 6.5% | 667,870 (+157.60%) | View |
| 2022-05-27 4:03 pm Sale | 13G | Baudax Bio Inc. BXRX | INTRACOASTAL CAPITAL LLC | 423,782 4.99% | -1,446,687 (-77.34%) | View |
| 2022-02-14 6:41 pm Purchase | 13G | Baudax Bio Inc. BXRX | ARMISTICE CAPITAL LLC | 8,869,545 9.99% | 4,526,076 (+104.20%) | View |
| 2022-01-06 4:03 pm Purchase | 13G | Baudax Bio Inc. BXRX | INTRACOASTAL CAPITAL LLC | 1,870,469 2.1% | 1,870,469 (New Position) | View |
| 2021-02-16 5:08 pm Purchase | 13G | Baudax Bio Inc. BXRX | ARMISTICE CAPITAL LLC | 4,343,469 9.99% | 3,443,893 (+382.84%) | View |
| 2021-02-16 3:39 pm Sale | 13G | Baudax Bio Inc. BXRX | CORSAIR CAPITAL MANAGEMENT L.P. | 90,752 1% | -729,886 (-88.94%) | View |
| 2021-02-16 09:43 am Sale | 13G | Baudax Bio Inc. BXRX | CVI Investments Inc. | 0 0% | -1,076,923 (Position Closed) | View |
| 2021-02-12 4:58 pm Sale | 13G | Baudax Bio Inc. BXRX | Stonepine Capital Management LLC | 0 0% | -1,819,849 (Position Closed) | View |
| 2021-01-13 09:01 am Sale | 13G | Baudax Bio Inc. BXRX | Empery Asset Management LP | 1,000,000 2.6% | -1,923,078 (-65.79%) | View |
| 2021-01-07 11:23 am Sale | 13G | Baudax Bio Inc. BXRX | SABBY MANAGEMENT LLC | 0 0% | -1,041,441 (Position Closed) | View |
| 2020-10-30 10:30 am Purchase | 13G | Baudax Bio Inc. BXRX | SABBY MANAGEMENT LLC | 1,041,441 11% | 1,041,441 (New Position) | View |
| 2020-06-09 4:32 pm Sale | 13G | Baudax Bio Inc. BXRX | BlackRock Inc. BLK | 488,683 2.8% | -25,816 (-5.02%) | View |
| 2020-04-03 5:10 pm Purchase | 13G | Baudax Bio Inc. BXRX | ARMISTICE CAPITAL LLC | 899,576 4.99% | 899,576 (New Position) | View |
| 2020-04-02 4:43 pm Purchase | 13G | Baudax Bio Inc. BXRX | Stonepine Capital Management LLC | 1,819,849 9.99% | 1,819,849 (New Position) | View |
| 2020-04-02 09:59 am Purchase | 13G | Baudax Bio Inc. BXRX | CVI Investments Inc. | 1,076,923 6.3% | 1,076,923 (New Position) | View |